Next Article in Journal
Valorization of Sargassum muticum Biomass According to the Biorefinery Concept
Next Article in Special Issue
Marine Peptides: Bioactivities and Applications
Previous Article in Journal
Extraction, Isolation, Structural Characterization and Anti-Tumor Properties of an Apigalacturonan-Rich Polysaccharide from the Sea Grass Zostera caespitosa Miki
Previous Article in Special Issue
Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Use of Natural Antimicrobial Peptides and Bacterial Biopolymers for Cultured Pearl Production

1
Ifremer, Centre de Brest, BP 70, 29280 Plouzané, France
2
Ifremer UMR 5244 IHPE, UPVD, CNRS, Université de Montpellier, CC 80, F-34095 Montpellier, France
3
Ifremer, UMR 241 EIO, UPF-ILM-IRD, Labex Corail, BP 7004, 98719 Taravao, French Polynesia
4
Faculty of Sciences, Biochemistry Department, Section III, Lebanese University, Tripoli, Lebanon
5
AiMB. 17 Rue d'Ouessant, 29280 Plouzané, France
*
Author to whom correspondence should be addressed.
Mar. Drugs 2015, 13(6), 3732-3744; https://doi.org/10.3390/md13063732
Submission received: 5 March 2015 / Revised: 20 May 2015 / Accepted: 27 May 2015 / Published: 11 June 2015
(This article belongs to the Special Issue Marine Peptides and Their Mimetics)

Abstract

:
Cultured pearls are the product of grafting and rearing of Pinctada margaritifera pearl oysters in their natural environment. Nucleus rejections and oyster mortality appear to result from bacterial infections or from an inappropriate grafting practice. To reduce the impact of bacterial infections, synthetic antibiotics have been applied during the grafting practice. However, the use of such antibiotics presents a number of problems associated with their incomplete biodegradability, limited efficacy in some cases, and an increased risk of selecting for antimicrobial resistant bacteria. We investigated the application of a marine antimicrobial peptide, tachyplesin, which is present in the Japanese horseshoe crab Tachypleus tridentatus, in combination with two marine bacterial exopolymers as alternative treatment agents. In field studies, the combination treatment resulted in a significant reduction in graft failures vs. untreated controls. The combination of tachyplesin (73 mg/L) with two bacterial exopolysaccharides (0.5% w/w) acting as filming agents, reduces graft-associated bacterial contamination. The survival data were similar to that reported for antibiotic treatments. These data suggest that non-antibiotic treatments of pearl oysters may provide an effective means of improving oyster survival following grafting procedures.

1. Introduction

The Tahiti pearl farming industry plays a major socio-economic role in French Polynesia. In an increasingly competitive market where the production of high quality pearls becomes essential, research can contribute to secure and ensure a durable production. Cultured pearls are the product of grafting and rearing of Pinctada margaritifera pearl oysters in their natural environment. Pearl culture includes several stages. To begin, the pearl oysters are collected and raised to serve either as donor or receiver. The grafting process then takes place following a surgical operation during which the graft, a small piece of mantle tissue, is inserted into the “pearl pocket” of the receiving oyster together with a nacre bead, the nucleus. Once inserted into the receiving oyster, the external epithelial-cells of the graft multiply to form a pearl sac around the nucleus [1]. The pearl sac then starts to deposit calcium carbonate polymorphs layers onto the nucleus. This is the starting point for the future pearl [2]. A rearing period of about 18 months is needed to finally produce a pearl with a sufficiently thick layer of nacre (0.8 mm) (Figure 1).
Figure 1. The different steps of the grafting process and pearl formation in the pearl oyster Pinctada margaritifera. (illustration C. Montagnani).
Figure 1. The different steps of the grafting process and pearl formation in the pearl oyster Pinctada margaritifera. (illustration C. Montagnani).
Marinedrugs 13 03732 g001
Unfortunately, nucleus rejections and oyster mortality occur for during the first 45 days following grafting. These phenomena, which typically affect 40% to 50% of oysters within three weeks following the operation, appears to result from bacterial infections or from an inappropriate grafting practice. The development of an inflammatory reaction after insertion of the nucleus and contamination by pathogenic bacteria, combined with the absence of rapid healing of the tissue incised during the graft are the most likely causes of nucleus rejection. Histological anomalies found in Pinctada margaritifera oysters could also indicate infection by a pathological agent or be due to grafting practice [3]. To prevent bacterial infections, anesthetics or synthetic antibiotics coated on nuclei have been applied during the grafting practice [4]. Antibiotics and antiseptics have been evaluated as a means of improving hygiene during nuclei insertion operations to reduce post-operative mortality and increase pearl quality [5]. However, the use of such antibiotics such as neomycin and oxytetracycline presents an environmental problem, due to their incomplete biodegradability, and a public health problem because of the potential for development of bacterial resistance.
Considering the tremendous diversity of marine organisms, they are expected to be a source of new products for marine biotechnology including biopolymers and bioactive metabolites. Indeed compounds from marine organisms provide a broad spectrum of natural products exhibiting a wide range of activities which include antimicrobial, antiviral, anticoagulant or antitumor effects [6].
Antimicrobial peptides (AMPs) play a major role in innate immunity, conserved in evolution, and are present in all phyla. They are mostly cationic and amphipathic molecules although they present a great diversity in terms of structural features as well as biological properties and functions. More than 1000 antimicrobial peptides have now been discovered in plants, vertebrates, and invertebrates [7,8,9].
A vast number of marine bacterial extracellular or intracellular biopolymers, such as exopolysaccharides (EPSs) and polyhydroxyalkanoates (PHAs), have been reported over recent decades, and their composition, structure, biosynthesis and functional properties have been extensively studied [10,11,12,13,14,15]. In the course of the discovery of novel biopolymers of biotechnological interest, it is widely accepted that micro-organisms originating from unusual ecosystems will provide a valuable resource not only for exploitation in novel biotechnological processes but also as models for investigating how biomolecules are stabilized when subjected to changing or extreme conditions [16,17,18]. Both biopolymers have been shown to possess either biological and/or filming properties [19,20].
The aim of this study was to evaluate the combination of tachyplesin, a marine antimicrobial peptide (AMP) with two bacterial exopolysaccharides as an alternative route to synthetic antibiotics used for cultured pearls. Experiments were first conducted under laboratory conditions using appropriate biopolymers and AMP then in in situ conditions in a pearl oyster farming.

2. Results and Discussion

The filming properties of exopolysaccharides depends on many parameters including their chemistry (chemical composition and conformation, branched or linear) and the chemistry of the environment as well. Uronic acids has been demonstrated to encourage adhesion of the polysaccharide onto the surfaces while Ca and Mg ions as present in seawater and oyster induce strong interactions with hydroxyl groups [21,22]. More than 32 exopolysaccharides synthesized by marine bacteria were produced under laboratory conditions for further evaluations. Based on previous information on the chemistry of EPSs and on technical and industrial considerations as well, two EPSs were selected. The chemical composition of the two EPS is listed in Table 1. The first polymer designated as Mo245 was produced by a bacterium isolated in the lagoon of Moorea Island (French Polynesia), belonging to the Vibrio genus. During stationary phase growth in batch cultures in the presence of glucose, this bacterium produced a high molecular weight EPS characterized by equal amounts of uronic acid and hexosamine (N-acetyl glucosamine and N-acetyl galactosamine) along with traces of galactose. EPS designated as GG was provided by G. Geesey from Montana State University (USA). This EPS was mainly composed of neutral sugars as glucose and showed a high polydispersity index (Ip = 4.2) reflecting the heterogeneity of polymer and a relatively low (870 kDa) molecular mass. Low protein content is indicative of a high degree of purity for both exopolymers.
Table 1. Chemical composition of the two bacterial EPSs (% total sugars). Nd: non-determined; Gal: Galactose; Glc: Glucose.
Table 1. Chemical composition of the two bacterial EPSs (% total sugars). Nd: non-determined; Gal: Galactose; Glc: Glucose.
GenusRef.ProteinsNeutral SugarsUronic AcidsHexosaminesSubstituants
VibrioMo 245<12 (Gal)4040Acetate
NdGG<190 (Glc)Tr (<5)--

2.1. SEM Analysis

SEM analysis demonstrated the formation of a homogeneous film (0.5 µm to 1 µm thick) on nuclei treated with the two exopolysaccharides and AMP/EPS mixtures. These films were shown to be stable following water rinse cycles. Compared to conventional commercial nuclei, filming with these biopolymers significantly reduced surface asperities with a smoothing effect (Figure 2).
Figure 2. SEM of coated nuclei. Left: EPS/AMP coated nucleus (Scraping indicated the presence of a homogeneous film). Right: Commercial nucleus.
Figure 2. SEM of coated nuclei. Left: EPS/AMP coated nucleus (Scraping indicated the presence of a homogeneous film). Right: Commercial nucleus.
Marinedrugs 13 03732 g002

2.2. Biopolymer Antibacterial Activity

The antibacterial activity reported for some bacterial strains has been proposed to be due to either polyanionic macromolecules including proteins and exopolysaccharides suggested to inhibit bacterial respiration [23,24] or cell-bound brominated compounds [25,26,27]. While several authors reported antimicrobial effects against various bacteria for EPSs [28,29], we did not find any evidence of an antimicrobial activity or of cytotoxicity for any of the all exopolysaccharides considered in the present study. Similar results were found for both marine and non-marine microbial strains tested.

2.3. Laboratory Experiments

With the aim to investigate the existence of bacterial pathogens associated with post graft mortalities, a total of 204 bacterial colonies exhibiting various colors, shapes and size were isolated during grafting operations of the cultivated pearl oysters P. margaritifera. Ninety-nine bacteria have been isolated from graft and 105 from pearl pouch. Phenotypic analyses revealed that Gram negative bacteria represent 75% of the isolated strains and Vibrio are the predominant bacteria. In samples collected from pearl pouch several days after the graft, Vibrio represents 63% of the Gram negative bacteria.
In that four experimental conditions (A to D) were tested under laboratory conditions including biopolymers alone (A and C) and tachyplesin associated with EPSs (B and D). After 3 months of storage, all coated nuclei B and D (EPS + tachyplesin) still inhibited Vibrio growth. Coating with EPS preserved the antimicrobial activity of the peptide (Figure 3).
Figure 3. Bacterial growth of a suspension of Vibrio (pMAR-02-149) after incubation in the presence of (A) uncoated nuclei; (B) coated nuclei EPS Mo 245 and tachyplesin.
Figure 3. Bacterial growth of a suspension of Vibrio (pMAR-02-149) after incubation in the presence of (A) uncoated nuclei; (B) coated nuclei EPS Mo 245 and tachyplesin.
Marinedrugs 13 03732 g003

2.4. In Situ Experiments

Approximatively, 500 grafts were performed for each nuclei condition. Nucleus retention and oyster mortality rates were evaluated after 40 days and 15 months of immersion under natural conditions (Figure 4). After 40 days no significant differences were observed within the four different experimental conditions (A, B, C and D). However, the EPS Mo245 associated with the tachyplesin (B) showed a better retention rate than the non coated nucleus (F) and as good as the commercial one (E) (Figure 5A,B). Additionally, coating with tachyplesin-EPSs solution induced a lesser oyster mortality compared to non-treated samples and a similar mortality to commercialized antibiotic treated nuclei.
Figure 4. Pearl oysters culture after grating. (A) During the first 40 days after the graft, pearl oysters are cultured in retention baskets to assess the rejection of nucleus; (B) The shells are then drilled on the side and pearl oysters are tied with a nylon thread to a cord.
Figure 4. Pearl oysters culture after grating. (A) During the first 40 days after the graft, pearl oysters are cultured in retention baskets to assess the rejection of nucleus; (B) The shells are then drilled on the side and pearl oysters are tied with a nylon thread to a cord.
Marinedrugs 13 03732 g004
Figure 5. Evaluation of the nuclei retention rate depending on its coating (A) Experimental grafting protocol used to evaluate EPS and EPS/PAM experimental nuclei (A to D conditions) with its controls, commercial nuclei (E) and non-coated nuclei (F). Only one nucleus size was used (2.4 BU). Each donor oyster contributed equally to the 6 tested conditions (A to F); (B) Nucleus retention rate of grafted pearl oysters (40 days post-graft) depending on the nucleus used. The number of pearl oysters is indicated above each histogram. Statistically homogeneous group are shown by a letter (a, b) inside the histograms using a Chi-2 test at significance level of 0.05.
Figure 5. Evaluation of the nuclei retention rate depending on its coating (A) Experimental grafting protocol used to evaluate EPS and EPS/PAM experimental nuclei (A to D conditions) with its controls, commercial nuclei (E) and non-coated nuclei (F). Only one nucleus size was used (2.4 BU). Each donor oyster contributed equally to the 6 tested conditions (A to F); (B) Nucleus retention rate of grafted pearl oysters (40 days post-graft) depending on the nucleus used. The number of pearl oysters is indicated above each histogram. Statistically homogeneous group are shown by a letter (a, b) inside the histograms using a Chi-2 test at significance level of 0.05.
Marinedrugs 13 03732 g005aMarinedrugs 13 03732 g005b
At the end of the experiments (To +15 months), and compared to commercial nuclei (E), nuclei treated with an EPS/AMP mixture showed a significant increase of pearls of high commercial value (assigned mainly to the proportion of round to semi-round high grade pearls). Furthermore, a decrease in the proportion of keshis was observed comparing EPS/AMP nuclei to non-coated nuclei (F). Keshi pearls correspond to non-nucleated pearls typically formed as by-products of pearl cultivation and referred to those pearls formed when a bead nucleus was rejected. Because they have no nucleus, keshi pearls are composed entirely of P. margaritifera nacre (Figure 6). Identical results were observed with nuclei coated with the mixture EPS-tachyplesin and commercialized ones. This is interesting because the results obtained with an environmentally friendly coating are as good as with commercial nucleus. Another advantage to using exopolysaccharide associated with AMP is their binding capability. Bacterial EPSs contain ionizable functional groups such as carboxyl, amine, sulfate and to a lesser extent hydroxyl groups that enable these biopolymers to bind metals [30,31]. Chelation of calcium and magnesium by these exopolysaccharides is in favor of the formation of an homogeneous nacre at the end of the biomineralization process [32].
Figure 6. Keshi pearls produced by the pearl oyster Pinctada margaritifera.
Figure 6. Keshi pearls produced by the pearl oyster Pinctada margaritifera.
Marinedrugs 13 03732 g006

3. Material and Methods

3.1. Microbial Biopolymers

Marine bacteria associated with unusual physical and chemical microenvironments have demonstrated their ability to produce unusual extracellular polymers in an aerobic carbohydrate-based medium including exopolysaccharides (EPSs) and polyhydroxyalkanoates (PHAs). Biopolymer production and subsequent chemical analyses of bacterial EPSs are described in previous works [33,34]. Briefly the global composition (neutral sugars, uronic acids, and hexosamine) of the different EPSs were determined using colorimetric methods, while monosaccharide composition and ratios were determined using GC and GC/MS analyses. Non carbohydrate substituants were characterized by HPLC and/or NMR analyses.

3.2. Antimicrobial Peptide

Many AMPs have already been isolated from different marine organisms [35]. Tachyplesin is an antimicrobial peptide extracted from hemocytes of the Japanese horseshoe crab Tachypleus tridentatus [36]. This AMP (KWCFRVCYRGICYRRCD) displays a potent activity against pathogenic marine Vibrios such as the ones present in pearl oysters [37,38]. Tachyplesin was produced by chemical synthesis by the subcontractant GeneCust (http://www.genecust.com/fr/). The synthetic peptide was analyzed by mass spectrometry and antimicrobial activity assay.

3.3. Nuclei

Nuclei were purchased from “Perles Nucleus Science Tahiti”, PNST (BP40146, Fare Tony, Papeete, Tahiti, French Polynesia).

3.4. Coated Nuclei Preparation

Nuclei were placed in an aqueous solution of exopolysaccharides (0.5% w/w) for a few hours under gentle agitation. The resulting coated nuclei were simply dried on an absorbent paper for 2 h at room temperature. The filming properties of biopolymers were then evaluated by Scanning Electron Microscopy (SEM).
EPS coated nuclei were then incubated for 48 h at 4 °C into an aqueous solution of tachyplesin at 73 mg/L (32 µM) corresponding to 10 times the MIC (Minimum inhibitory concentrations) as determined for strain Vibrio Pmar-02-149 involved in bacterial infections in Pinctada margaritifera. The resulting coated nuclei were dried for 24 h.

3.5. Scanning Electron Microscopy

For scanning electron microscopy (SEM), dried filmed nucleus was mounted on scanning electron microscopy sample stub and coated in a vacuum with 150 Å of gold (SCD040, Balzers Union, Liechtenstein). Samples were observed using an FEI Quanta 200 scanning electron microscope.

3.6. Antimicrobial Activity and Cytotoxicity of the Molecules

Antimicrobial activity of exopolysaccharides (EPS) was assayed against several bacteria including the Gram-positive Micrococcus luteus CIP 53.45 and Bacillus subtilis ATCC 6633, and Gram-negative Escherichia coli SBS 363, E. coli ATCC 8739, Staphylococcus aureus ATCC 6538 and Pseudomonas aeruginosa ATCC 9027 along with marine surface pioneering bacteria (Flavobacterium spp., Vibrio natriegens, Alteromonas macleodii, Pseudomonas spp. and Pseudoalteromonas spp.). Moreover, several marine Vibrio spp. isolated from pearl oyster Pinctada margaritifera (Vibrio tubiashi EL2, Vibrio harveyi Takapoto 177, Vibrio SP1 Pmar-02-149) along with the fungal pathogen Candida albicans ATCC 10231 were also used to evaluate the activity spectrum. Minimal inhibitory concentrations (MIC) were investigated in duplicate by the liquid growth inhibition assay based on the procedure previously described [39]. EPS cellular toxicity was evaluated by a hemolytic assay as described by Niidome et al. (2000) [40] using sheep blood cells (BioMérieux, France).

3.7. Antimicrobial Property of Coated Nuclei

Prior to experiments conducted under natural conditions, the antimicrobial property of the tachyplesin was evaluated in the presence of EPSs acting as filming agents. The direct grafting of tachyplesin on nuclei was also compared to the association of the antimicrobial peptide and biopolymers. The antimicrobial activity of coated nuclei was analyzed as previously described by liquid growth inhibition assay. Coated or uncoated nuclei were incubated in a suspension of Vibrio SP1 Pmar in Poor Broth supplemented with NaCl 0.5 M. After under gentle agitation during 18 h at 20 °C, the bacterial suspensions were transferred on microplates. Growth was monitored spectrophotometrically at 620 nm on a Multiscan microplate reader. Besides, serial dilutions of the bacterial suspension were plated onto Zobell agar plates and colonies were counted after 24 h incubation at 20 °C.

3.8. In Situ Experiments

In situ experiments were performed at the Gauguin’s Pearl farm on the atoll of Rangiroa in French Polynesia in June 2011. Up to 3050 nuclei were treated with the two EPSs or associated with the tachyplesin and compared to non-treated samples and nuclei covered with an antibiotic containing synthetic polymer (commercial nuclei, PNST society, Tahiti). The conventional coating protocol of the PNST society was used. Briefly 1 kg of nuclei (approximately 2000 nuclei size 2.4 BU, a Japanese measure which equals to approximately 7.2 mm diameter) were placed in a rotating drum (2 rev/min) and the EPS solution (5 g/L) was injected in 5 times of 10 mL (total 50 mL) for 90 min at temperature room. The nuclei were then placed under vacuum for final drying for 2 to 3 h at room temperature and further stored at 4 °C under vacuum bag free of air. Resulting nuclei are referenced as A and C for EPS Mo 245 and GG, respectively.
For the grafting of tachyplesin, 1000 nuclei A and C were incubated in an aqueous solution of tachyplesin at 73 mg/L (32 µM). For this purpose, the tachyplesin solution (73 mg/L) was injected into the rotating drum following the same procedure as that used for EPS. The resulting EPS/AMP nuclei were recovered, dried under vacuum, and preserved at 4 °C in sealed bags. These were designated as nuclei B and D for EPS Mo 245 + tachyplesin and EPS GG + tachyplesin, respectively.
All coated nuclei were compared to either commercial nuclei coated with an antibiotics containing synthetic polymer (positive control, designated as nuclei E) or non-treated samples nuclei (negative control designated as nuclei F).

4. Conclusions

The use of antibiotics combined with petrochemical derived polymer covering the nucleus used in pearl culture could be detrimental for the environment. A marine peptide, the tachyplesin, associated with two bacterial exopolysaccharides acting as filming agents, gave similar performances to antibiotics in terms of both oyster mortality and nucleus rejection rates. Bacterial exopolysaccharides formed a homogeneous and stable coating on the nucleus while the presence of incorporated tachyplesin ensured the desired antimicrobial property. The use of these environmental friendly coatings combined with a marine peptide could be considered as a promising green alternative to prevent costly bacterial infections in pearl farming industry. In terms of both an environmental and economical point of view, tachyplesin associated with either EPSs gave satisfactory data for professionals compared to commercial treatments. Optimization studies are in progress to improve both the coating protocol and the tachyplesin/EPS ratio with the aim of obtaining high grade quality pearls. In a similar way, additional experiments are conducted with Polyhydroxyalkanoates (PHAs) [41]. PHAs are non-water soluble polymers and form a stable film on the surface of the nucleus. Interesting data were observed after 30 days of exposure, in that such polymers are expected to preserve the antimicrobial activity of the tachyplesin. Long term experiments are in progress to evaluate PHAs as filming agents associated with AMP.

Acknowledgments

This study was part of a collaborative project (GDR ADEQUA) supported by the “Direction des Ressources Marines et Minières” of French Polynesia. It was also supported by Ifremer. Authors are grateful to Corinne Belliard, Julie Fievet, Adrien Santini, Kevin Magre, Peva Levy and Cedrik Lo for helpful discussions and technical assistance. Authors also thanks Philippe Cabral and the staff of the farm Gauguin’s pearl in Rangiroa (French Polynesia).

Author Contributions

Jean Guezennec, Christelle Simon-Colin, Yannick Gueguen and Evelyne Bachere conceived and designed the different experiments. Christelle Simon-Colin, Achraf Kouzayha and Denis Saulnier performed the experiments and Nicolas Gayet performed SEM analyses. Jean Guezennec, Christelle Simon-Colin, Yannick Gueguen and Evelyne Bachere analyzed the data and Jean Guezennec wrote the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cochennec-Laureau, N.; Montagnani, C.; Saulnier, D.; Fougerouse, A.; Levy, P.; Lo, C. A histological examination of grafting success in pearl oyster Pinctada margaritifera in French Polynesia. Aquat. Living Resour. 2010, 23, 131–140. [Google Scholar] [CrossRef]
  2. Gueguen, Y.; Montagnani, C.; Joubert, B.; Marie, C.; Belliard, A.; Tayale, J.; Fievet, P.; Levy, D.; Piquemal, F.; Marin, G.; et al. Characterization of Molecular Processes Involved in the Pearl Formation in Pinctada margaritifera for the Sustainable Development of Pearl Farming Industry in French Polynesia. In Recent Advances in Pearl Research—Proceedings of the International Symposium on Pearl Research 2011; Watabe, S., Maeyama, K., Nagasawa, H., Eds.; Terrapub: Tokyo, Japan, 2013; pp. 183–193. [Google Scholar]
  3. Comps, M.; Fougerouse, A.; Bustles, D. A prokaryote infecting the black-lipped pearl oyster Pinctada margaritifica. J. Invertebr. Pathol. 1998, 72, 87–89. [Google Scholar] [CrossRef] [PubMed]
  4. Norton, J.H.; Lucas, J.S.; Turner, I.; Mayer, R.J.; Newnham, R. Approaches to improve cultured pearl formation in Pinctada margaritifera through use of relaxation, antiseptic application and incision closure during bead insertion. Aquaculture 2000, 184, 1–17. [Google Scholar] [CrossRef]
  5. Southgate, P.; Lucas, J. The Pearl Oyster; Southgate, P., Lucas, J., Eds.; Elsevier: Oxford, UK, 2008; p. 544. [Google Scholar]
  6. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2011, 28, 196–268. [Google Scholar] [CrossRef] [PubMed]
  7. Tossi, A.; Sandri, L. Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. Curr. Pharm. Des. 2002, 8, 743–761. [Google Scholar] [CrossRef] [PubMed]
  8. Brogden, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238–250. [Google Scholar] [CrossRef] [PubMed]
  9. Brahmachary, M.; Krishnan, S.T.P.; Koh, J.L.Y.; Khan, A.M.; Seah, S.H.; Tan, T.W.; Brusic, V.; Bajic, V.B. ANTIMIC: A database of antimicrobial sequences. Nucleic Acids Res. 2004, 32, D586–D589. [Google Scholar] [CrossRef] [PubMed]
  10. Rougeaux, H.; Kervarec, N.; Pichon, R.; Raguenes, G.; Guezennec, J. Novel bacterial exopolysaccharides from deep-sea hydrothermal vents. Carbohydr. Polym. 1996, 31, 237–242. [Google Scholar] [CrossRef]
  11. Sutherland, I. A sticky business: Microbial polysaccharides; Current products and future trends. Microbiol. Today 2002, 29, 70–71. [Google Scholar]
  12. Kumar, S.; Mody, K.; Jha, B. Bacterial exopolysaccharides—A perception. J. Basic. Microbiol. 2007, 47, 103–117. [Google Scholar] [CrossRef] [PubMed]
  13. Rehm, B.H.A. (Ed.) Microbial Production of Biopolymers and Polymer Precursors: Applications and Perspectives; Caister Academic Press: Norfolk, UK, 2009.
  14. Ullrich, M. (Ed.) Bacterial Polysaccharides: Current Innovations and Future Trends; Caister Academic Press: Norfolk, UK, 2009.
  15. Guezennec, J. Deep-sea hydrothermal vents: A new source of innovative bacterial exopolysaccharides of biotechnological interest? J. Ind. Microbiol. Biotechnol. 2002, 29, 204–208. [Google Scholar] [CrossRef] [PubMed]
  16. Nichols, C.A.; Guezennec, J.; Bowman, J.P. Bacterial exopolysaccharides from extreme marine environments with special consideration of the southern ocean, sea ice, and deep-sea hydrothermal vents: A review. Mar. Biotechnol. 2005, 7, 253–271. [Google Scholar] [CrossRef] [PubMed]
  17. Nicolaus, B.; Kambourova, M.; Toksoy Oner, E. Exopolysaccharides from extremophiles: From fundamental to biotechnology. Environ. Technol. 2010, 31, 1145–1158. [Google Scholar] [CrossRef] [PubMed]
  18. Guezennec, J.; Moppert, X.; Raguenes, G.; Richert, L.; Costa, B.; Simon Colin, C. Microbial mats in French Polynesia and their biotechnological applications. Process Biochem. 2011, 46, 16–22. [Google Scholar] [CrossRef]
  19. Colliec-Jouault, S.; Zanchetta, P.; Helley, D.; Ratiskol, J.; Sinquin, C.; Fischer, A.M.; Guézennec, J. Exopolysaccharides produced by bacteria isolated from deep-sea hydrothermal vents: New agents with therapeutic potential. Pathol. Biol. 2004, 52, 127–130. [Google Scholar] [CrossRef] [PubMed]
  20. Guezennec, J.; Herry, J.M.; Kouzayha, A.; Bachere, E.; Mittelman, M.W.; Bellon Fontaine, M.-N. Exopolysaccharides from unusual marine environments inhibit early stages of biofouling. Int. Biodeterior. Biodegrad. 2012, 66, 1–7. [Google Scholar] [CrossRef]
  21. Körstgens, V.; Flemming, H.-C.; Wingender, J.; Borchard, W. Influence of calcium ions on the mechanical properties of a model biofilm of mucoid Pseudomonas aeruginosa. Water Sci. Technol. 2001, 43, 49–57. [Google Scholar] [PubMed]
  22. Flemming, H.-C.; Wingender, J. The biofilm matrix. Nat. Rev. 2010, 8, 623–633. [Google Scholar] [CrossRef] [PubMed]
  23. Gauthier, M.J. Alteromonas rubra sp. nov a new marine antibiotic-producing bacterium. Int. J. Syst. Bacteriol. 1979, 26, 459–466. [Google Scholar] [CrossRef]
  24. Holmstrøm, C.; Egan, S.; Franks, A.; McCLoy, S.; Kjelleberg, S. Antifouling activities expressed by marine surface associated Pseudoalteromonas species. FEMS Microbiol. Ecol. 2002, 41, 47–58. [Google Scholar] [CrossRef]
  25. Gauthier, M.J.; Flatau, G.N. Antibacterial activity of marine violet-pigmented Alteromonas with special reference to the production of brominated compounds. Can. J. Microbiol. 1976, 22, 1612–1619. [Google Scholar] [CrossRef] [PubMed]
  26. Bowman, J.P. Bioactive compound synthetic capacity and ecological significance of marine bacterial genus Pseudoalteromonas. Mar. Drugs 2007, 5, 220–241. [Google Scholar] [CrossRef] [PubMed]
  27. Onbasli, D.; Aslim, B. Determination of antimicrobial activity and production of some metabolites by Pseudomonas aeruginosa B1 and B2 in sugar beet molasses. Afr. J. Biotechnol. 2008, 7, 4614–4619. [Google Scholar]
  28. Pandey, A.; Naik, M.; Dubey, S.K. Hemolysin, protease, and EPS producing pathogenic Aeromonas hydrophila strain An4 shows antibacterial activity against marine bacterial fish pathogens. J. Mar. Biol. 2010, 10, 1–9. [Google Scholar] [CrossRef]
  29. Shankar, S.; Jeba Malar, A.; Punitha, S.M.J. Antimicrobial activity of marine bacteria associated with polychaetes. Biores. Bull. 2010, 1, 24–28. [Google Scholar]
  30. Moppert, X.; le Costaouec, T.; Raguénès, G.; Simon-Colin, C.; Crassous, P.; Costa, B.; Guezennec, J. Investigation into the uptake of copper, iron and selenium by a highly sulphated bacterial exopolysaccharide isolated from microbial mats. J. Ind. Microbiol. Biotechnol. 2009, 36, 599–604. [Google Scholar] [CrossRef] [PubMed]
  31. Deschatre, M.; Ghillebaert, F.; Guezennec, J.; Simon-Colin, C. Sorption of copper(II) and silver(I) by four bacterial exopolysaccharides. Appl. Biochem. Biotech. 2013, 171, 1313–1327. [Google Scholar] [CrossRef] [PubMed]
  32. Guezennec, J.; Simon-Colin, C.; Kouzayha, A.; Gueguen, Y.; Bachere, E. Nucleus Coated with a Film-Forming Coating Having Antibacterial and Cicatrizing Properties and the Method for Obtaining Same. U.S. Patent 20130152865, 20 June 2013. [Google Scholar]
  33. Guezennec, J.; Pignet, P.; Raguenes, G.; Deslandes, E.; Lijour, Y.; Gentric, E. Preliminary chemical characterization of unusual eubacterial exopolysaccharides of deep-sea origin. Carbohydr. Polym. 1994, 24, 287–295. [Google Scholar] [CrossRef]
  34. Raguénès, G.; Peres, A.; Ruimy, R.; Pignet, P.; Christen, R.; Loaec, M.; Rougeaux, H.; Barbier, G.; Guezennec, J. Alteromonas infernus sp. nov, a new polysaccharide producing bacterium isolated from a deep-sea hydrothermal vent. J. Appl. Bacteriol. 1997, 82, 422–430. [Google Scholar] [CrossRef]
  35. Sperstad, S.V.; Haug, T.; Blenck, H.-M.; Styrvold, O.B.; Li, C.; Stensvag, K. Antimicrobial peptides from marine invertebrates: Challenges and perspectives in marine antimicrobial peptide discovery. Biotech. Adv. 2011, 29, 519–530. [Google Scholar] [CrossRef] [PubMed]
  36. Nakamura, T.; Furunaka, H.; Miyata, T.; Tokunaga, F.; Muta, T.; Iwanaga, S.; Niwa, M.; Takao, T.; Shimonishi, Y. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J. Biol. Chem. 1998, 263, 16709–16713. [Google Scholar]
  37. Muta, T.; Iwanaga, S. Tachyplesin and anti-lipopolysaccharide factor. Methods Mol. Biol. 1997, 78, 63–71. [Google Scholar] [PubMed]
  38. Morvan, A.; Iwanaga, S.; Comps, M.; Bachere, E. In vitro activity of the limulus antimicrobial peptide Tachyplesin I on marine bivalve pathogens. J. Invertebr. Pathol. 1997, 69, 177–182. [Google Scholar] [CrossRef] [PubMed]
  39. Destoumieux, D.; Bulet, P.; Loew, D.; van Dorsselaer, A.; Rodriguez, J.; Bachère, E. Penaeidins: A new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda). J. Biol. Chem. 1997, 272, 28398–28406. [Google Scholar] [CrossRef] [PubMed]
  40. Niidome, T.; Tsuiki, M.; Tokunaga, Y.; Hatakeyama, T.; Aoyagi, H. Antibacterial activity of Arg/Pro-rich bactenecin 5 model peptides and their interaction with phospholipid membranes. Bull. Chem. Soc. Jpn. 2000, 73, 1397–1402. [Google Scholar] [CrossRef]
  41. Guezennec, J.; Simon-Colin, C.; Kouzayha, A.; Bachere, E. Nucleus Covered with PHA. U.S. Patent 20130263793, 10 October 2013. [Google Scholar]

Share and Cite

MDPI and ACS Style

Simon-Colin, C.; Gueguen, Y.; Bachere, E.; Kouzayha, A.; Saulnier, D.; Gayet, N.; Guezennec, J. Use of Natural Antimicrobial Peptides and Bacterial Biopolymers for Cultured Pearl Production. Mar. Drugs 2015, 13, 3732-3744. https://doi.org/10.3390/md13063732

AMA Style

Simon-Colin C, Gueguen Y, Bachere E, Kouzayha A, Saulnier D, Gayet N, Guezennec J. Use of Natural Antimicrobial Peptides and Bacterial Biopolymers for Cultured Pearl Production. Marine Drugs. 2015; 13(6):3732-3744. https://doi.org/10.3390/md13063732

Chicago/Turabian Style

Simon-Colin, Christelle, Yannick Gueguen, Evelyne Bachere, Achraf Kouzayha, Denis Saulnier, Nicolas Gayet, and Jean Guezennec. 2015. "Use of Natural Antimicrobial Peptides and Bacterial Biopolymers for Cultured Pearl Production" Marine Drugs 13, no. 6: 3732-3744. https://doi.org/10.3390/md13063732

APA Style

Simon-Colin, C., Gueguen, Y., Bachere, E., Kouzayha, A., Saulnier, D., Gayet, N., & Guezennec, J. (2015). Use of Natural Antimicrobial Peptides and Bacterial Biopolymers for Cultured Pearl Production. Marine Drugs, 13(6), 3732-3744. https://doi.org/10.3390/md13063732

Article Metrics

Back to TopTop